Antihyperuricemic Agents Market
Antihyperuricemic agents are also called anti-gout drugs. These drugs correct the overproduction ... Read More
Mucoactive agents are a class of chemicals that help clear mucus or sputum from the upper and lower airways, including the lungs, bronchi, and trachea, and are used to treat respiratory diseases complicated by excessive secretion or concentration of mucus.
This report contains market size and forecasts of Mucoactive Agents in global, including the following market information:
Global Mucoactive Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mucoactive Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mucoactive Agents companies in 2021 (%)
The global Mucoactive Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Expectorants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mucoactive Agents include AstraZeneca, Boehringer Ingelheim International, GlaxoSmithKline, Novartis AG, Teva Pharmaceutical Industries, Sunovion Pharmaceuticals (Sumitomo Dainippon Pharma), CHIESI Farmaceutici S.p.A, Orion and LGM Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mucoactive Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mucoactive Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mucoactive Agents Market Segment Percentages, by Type, 2021 (%)
Expectorants
Mucolytics
Mucokinetics
Mucoregulators
Global Mucoactive Agents Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mucoactive Agents Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Mucoactive Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mucoactive Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mucoactive Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mucoactive Agents revenues share in global market, 2021 (%)
Key companies Mucoactive Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mucoactive Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim International
GlaxoSmithKline
Novartis AG
Teva Pharmaceutical Industries
Sunovion Pharmaceuticals (Sumitomo Dainippon Pharma)
CHIESI Farmaceutici S.p.A
Orion
LGM Pharma
Globe Quimica
Alitair Pharmaceuticals
Citrique Belge
Afton Pharma
Gadot Biochemical Industries
Sanofi Aventis
Mylan
Allergan
Honor Bio-Pharm
BOC Sciences
Sinopharm Shantou Jinshi Pharmaceutical
Zhejiang Hengkang Pharmaceutical
Xiangyu Pharmaceutical
Zhejiang Kangle Pharmaceutical
Shanghai Pukang Pharmaceuticals
Hunan Dongting Citric Acid Chemicals
Livzon Pharmaceutical
Zhejiang Xinmingzhu Pharmaceutical
Antihyperuricemic agents are also called anti-gout drugs. These drugs correct the overproduction ... Read More
Anti-hyperlipidemic agents, also called lipid-lowering drugs, any drug that lowers the levels of ... Read More
Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a h ... Read More
An electronic infusion pump is a medical device that delivers fluids, such as nutrients and medic ... Read More